Brown Advisory
WST icon

Brown Advisory’s West Pharmaceutical WST Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$661M Sell
3,021,283
-247,195
-8% -$54.1M 0.87% 29
2025
Q1
$732M Buy
3,268,478
+716,442
+28% +$160M 1.05% 23
2024
Q4
$836M Buy
2,552,036
+266,488
+12% +$87.3M 1.06% 24
2024
Q3
$686M Buy
2,285,548
+528,153
+30% +$159M 0.86% 30
2024
Q2
$579M Buy
1,757,395
+119,518
+7% +$39.4M 0.76% 36
2024
Q1
$648M Buy
1,637,877
+223,446
+16% +$88.4M 0.87% 26
2023
Q4
$498M Buy
1,414,431
+109,369
+8% +$38.5M 0.7% 40
2023
Q3
$490M Buy
1,305,062
+35,788
+3% +$13.4M 0.8% 31
2023
Q2
$485M Buy
1,269,274
+18,613
+1% +$7.12M 0.76% 34
2023
Q1
$433M Buy
1,250,661
+39,220
+3% +$13.6M 0.73% 35
2022
Q4
$285M Sell
1,211,441
-5,352
-0.4% -$1.26M 0.53% 51
2022
Q3
$299M Buy
1,216,793
+236,270
+24% +$58.1M 0.58% 47
2022
Q2
$296M Sell
980,523
-207,226
-17% -$62.7M 0.56% 47
2022
Q1
$488M Sell
1,187,749
-150,842
-11% -$62M 0.73% 36
2021
Q4
$628M Buy
1,338,591
+105,397
+9% +$49.4M 0.78% 34
2021
Q3
$524M Buy
1,233,194
+172,183
+16% +$73.1M 0.77% 36
2021
Q2
$381M Sell
1,061,011
-193,520
-15% -$69.5M 0.57% 46
2021
Q1
$354M Buy
1,254,531
+82,063
+7% +$23.1M 0.6% 46
2020
Q4
$332M Buy
1,172,468
+196,946
+20% +$55.8M 0.59% 46
2020
Q3
$268M Buy
975,522
+120,055
+14% +$33M 0.55% 46
2020
Q2
$194M Buy
855,467
+118,838
+16% +$27M 0.45% 53
2020
Q1
$112M Buy
736,629
+98,474
+15% +$15M 0.34% 67
2019
Q4
$95.9M Buy
638,155
+9,233
+1% +$1.39M 0.24% 90
2019
Q3
$89.2M Buy
628,922
+190,868
+44% +$27.1M 0.25% 82
2019
Q2
$54.8M Buy
438,054
+96,670
+28% +$12.1M 0.16% 130
2019
Q1
$37.6M Sell
341,384
-231,067
-40% -$25.5M 0.11% 165
2018
Q4
$56.1M Buy
572,451
+24,797
+5% +$2.43M 0.19% 98
2018
Q3
$67.6M Buy
547,654
+69,424
+15% +$8.57M 0.19% 97
2018
Q2
$47.5M Buy
478,230
+49,797
+12% +$4.94M 0.15% 129
2018
Q1
$37.8M Buy
428,433
+301,604
+238% +$26.6M 0.12% 152
2017
Q4
$12.5M Buy
126,829
+124,227
+4,774% +$12.3M 0.04% 285
2017
Q3
$250K Buy
2,602
+40
+2% +$3.84K ﹤0.01% 1059
2017
Q2
$242K Buy
2,562
+73
+3% +$6.9K ﹤0.01% 1085
2017
Q1
$203K Buy
+2,489
New +$203K ﹤0.01% 1110